Role of neuroinflammation in neurodegenerative diseases (Review)

Molecular Medicine Reports

Volumn 13, Issue 4, 2016, Pages 3391-3396

  Chen, Wei Wei ^a   Zhang, Xia ^a   Huang, Wen Juan ^a  

^a XUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Astrocytes; Astroglia; Cytokines; Neurodegeneration; Neuroinflammation

Indexed keywords

ARTICLE; DEGENERATIVE DISEASE; DEPRESSION; HUMAN; INFECTION; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; AGING; AMYOTROPHIC LATERAL SCLEROSIS; COMPLICATION; INFLAMMATION; METABOLIC DISORDER; METABOLISM; MICROGLIA; PATHOLOGY; VIRUS INFECTION;

CYTOKINE;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; CYTOKINES; HUMANS; INFLAMMATION; METABOLIC DISEASES; MICROGLIA; NEURODEGENERATIVE DISEASES; VIRUS DISEASES;

EID: 84963891323     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.4948     Document Type: Article

References (84)

1. Campbell IL, Krucker T, Steffensen S, Akwa Y, Powell HC, Lane T, Carr DJ, Gold LH, Henriksen SJ and Siggins GR: Structural and functional neuropathology in transgenic mice with CNS expression of IFN-α. Brain Res 835: 46-61, 1999.
2. Hof PR and Mobbs CV (eds): Handbook of the neuroscience of aging. Elsevier/Academic Press, Amsterdam, pp1-53, 2010.
3. Yuan J and Yankner BA: Apoptosis in the nervous system. Nature 407: 802-809, 2000.
4. Przedborski S, Vila M and Jackson-Lewis V: Neurodegeneration: What is it and where are we? J Clin Invest 111: 3-10, 2003.
5. Amor S, Puentes F, Baker D and van der Valk P: Inflammation in neurodegenerative diseases. Immunology 129: 154-169, 2010.
6. Shinya K, Shimada A, Ito T, Otsuki K, Morita T, Tanaka H, Takada A, Kida H and Umemura T: Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve. Arch Virol 145: 187-195, 2000.
7. Reinacher M, Bonin J, Narayan O and Scholtissek C: Pathogenesis of neurovirulent influenza A virus infection in mice. Route of entry of virus into brain determines infection of different populations of cells. Lab Invest 49: 686-692, 1983.
8. Jadidi-Niaragh F and Mirshafiey A: Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis. Neuropharmacology 59: 180-189, 2010.
9. Chastain EM, Duncan DS, Rodgers JM and Miller SD: The role of antigen presenting cells in multiple sclerosis. Biochim Biophys Acta 1812: 265-274, 2011.
10. Czirr E and Wyss-Coray T: The immunology of neurodegeneration. J Clin Invest 122: 1156-1163, 2012.
11. Ransohoff RM and Perry VH: Microglial physiology: Unique stimuli, specialized responses. Annu Rev Immunol 27: 119-145, 2009.
12. Perry VH and Teeling J: Microglia and macrophages of the central nervous system: The contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Sem Immunopathol 35: 601-612, 2013.
13. Schwartz M, Kipnis J, Rivest S and Prat A: How do immune cells support and shape the brain in health, disease, and aging? J Neurosci 33: 17587-17596, 2013.
14. Sofroniew MV and Vinters HV: Astrocytes: Biology and pathology. Acta Neuropathol 119: 7-35, 2010.
15. Wyss-Coray T and Mucke L: Inflammation in neurodegenerative disease-A double-edged sword. Neuron 35: 419-432, 2002.
16. Lull ME and Block ML: Microglial activation and chronic neurodegeneration. Neurotherapeutics 7: 354-365, 2010.
17. Das Sarma J: Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology. J Neurovirol 20: 122-136, 2014.
18. Glass CK, Saijo K, Winner B, Marchetto MC and Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934, 2010.
19. Teeling JL and Perry VH: Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: Underlying mechanisms. Neuroscience 158: 1062-1073, 2009.
20. Taylor JP, Hardy J and Fischbeck KH: Toxic proteins in neurodegenerative disease. Science 296: 1991-1995, 2002.
21. Chevalier-Larsen E and Holzbaur EL: Axonal transport and neurodegenerative disease. Biochim Biophys Acta 1762: 1094-1108, 2006.
22. Chen H and Chan DC: Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 18 (R2): R169-R176, 2009.
23. Allison DJ and Ditor DS: The common inflammatory etiology of depression and cognitive impairment: A therapeutic target. J Neuroinflammation 11: 151, 2014.
24. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J and Breteler MM: Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125: 765-772, 2002.
25. Schiffrin EL: Inflammation, immunity and development of essential hypertension. J Hypertens 32: 228-229, 2014.
26. Shimizu M, Ishikawa J, Yano Y, Hoshide S, Shimada K and Kario K: The relationship between the morning blood pressure surge and low-grade inflammation on silent cerebral infarct and clinical stroke events. Atherosclerosis 219: 316-321, 2011.
27. Tousoulis D, Kampoli AM, Papageorgiou N, Androulakis E, Antoniades C, Toutouzas K and Stefanadis C: Pathophysiology of atherosclerosis: The role of inflammation. Curr Pharm Des 17: 4089-4110, 2011.
28. Di Napoli M, Godoy DA, Campi V, Masotti L, Smith CJ, Parry Jones AR, Hopkins SJ, Slevin M, Papa F, Mogoanta L, et al: C-reactive protein in intracerebral hemorrhage: Time course, tissue localization, and prognosis. Neurology 79: 690-699, 2012.
29. Di Napoli M, Parry-Jones AR, Smith CJ, Hopkins SJ, Slevin M, Masotti L, Campi V, Singh P, Papa F, Popa-Wagner A, et al: C-reactive protein predicts hematoma growth in intracerebral hemorrhage. Stroke 45: 59-65, 2014.
30. Rizzo M, Corrado E, Coppola G, Muratori I, Mezzani A, Novo G and Novo S: The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis. Intern Med J 39: 539-545, 2009.
31. Rizzo M, Corrado E, Coppola G, Muratori I, Novo G and Novo S: Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. Coron Artery Dis 20: 15-20, 2009.
32. Goossens GH: The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 94: 206-218, 2008.
33. Goossens GH, Bizzarri A, Venteclef N, Essers Y, Cleutjens JP, Konings E, Jocken JW, Cajlaković M, Ribitsch V, Clément K, et al: Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 124: 67-76, 2011.
34. Howcroft TK, Campisi J, Louis GB, Smith MT, Wise B, Wyss-Coray T, Augustine AD, McElhaney JE, Kohanski R and Sierra F: The role of inflammation in age-related disease. Aging (Albany NY) 5: 84-93, 2013.
35. Olefsky JM and Glass CK: Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219-246, 2010.
36. Bruunsgaard H, Pedersen M and Pedersen BK: Aging and proinflammatory cytokines. Curr Opin Hematol 8: 131-136, 2001.
37. Fagiolo U, Cossarizza A, Santacaterina S, Ortolani C, Monti D, Paganelli R and Franceschi C: Increased cytokine production by peripheral blood mononuclear cells from healthy elderly people. Ann N Y Acad Sci 663: 490-493, 1992.
38. Fagiolo U, Amadori A, Cozzi E, Bendo R, Lama M, Douglas A and Palù G: Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging (Milano) 5: 451-458, 1993.
39. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C and Paganelli R: Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23: 2375-2378, 1993.
40. Johnson FA, Dawson AJ and Meyer RL: Activity-dependent refinement in the goldfish retinotectal system is mediated by the dynamic regulation of processes withdrawal: An in vivo imaging study. J Comp Neurol 406: 548-562, 1999.
41. Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, Maisano C, Jones L, Murrah NV and Vaccarino V: Depressive symptoms and metabolic syndrome: Is inflammation the underlying link? Biol Psychiatry 64: 896-900, 2008.
42. Ouchi N, Parker JL, Lugus JJ and Walsh K: Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97, 2011.
43. Capuron L, Poitou C, Machaux-Tholliez D, Frochot V, Bouillot JL, Basdevant A, Layé S and Clément K: Relationship between adiposity, emotional status and eating behaviour in obese women: Role of inflammation. Psychol Med 41: 1517-1528, 2011.
44. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, et al: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54: 2277-2286, 2005.
45. McCrimmon RJ, Ryan CM and Frier BM: Diabetes and cognitive dysfunction. Lancet 379: 2291-2299, 2012.
46. McIntyre RS, Soczynska JK, Konarski JZ, Woldeyohannes HO, Law CW, Miranda A, Fulgosi D and Kennedy SH: Should depressive syndromes be reclassified as 'metabolic syndrome type II'? Ann Clin Psychiatry 19: 257-264, 2007.
47. Wolkowitz OM, Epel ES, Reus VI and Mellon SH: Depression gets old fast: Do stress and depression accelerate cell aging? Depress Anxiety 27: 327-338, 2010.
48. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, et al: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STARD report. Am J Psychiatry 163: 1905-1917, 2006.
49. Baune BT, Smith E, Reppermund S, Air T, Samaras K, Lux O, Brodaty H, Sachdev P and Trollor JN: Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 37: 1521-1530, 2012.
50. Najjar S, Pearlman DM, Devinsky O, Najjar A and Zagzag D: Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: A review of clinical and experimental evidence. J Neuroinflammation 10: 142, 2013.
51. Zunszain PA, Hepgul N and Pariante CM: Inflammation and depression. Curr Top Behav Neurosci 14: 135-151, 2013.
52. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR and Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 593-602, 2005.
53. Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, Pi B, Thurmond L and Bilello JA: Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: A pilot and replication study. Mol Psychiatry 18: 332-339, 2013.
54. Rivest S: Regulation of innate immune responses in the brain. Nat Rev Immunol 9: 429-439, 2009.
55. Yang WX, Terasaki T, Shiroki K, Ohka S, Aoki J, Tanabe S, Nomura T, Terada E, Sugiyama Y and Nomoto A: Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229: 421-428, 1997.
56. Aronsson F, Robertson B, Ljunggren HG and Kristensson K: Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system. Viral Immunol 16: 415-423, 2003.
57. Schnell G, Joseph S, Spudich S, Price RW and Swanstrom R: HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog 7: e1002286, 2011.
58. Chen L, Liu J, Xu C, Keblesh J, Zang W and Xiong H: HIV-1gp120 induces neuronal apoptosis through enhancement of 4-aminopyridine-senstive outward K+ currents. PLoS One 6: e25994, 2011.
59. Chang JR, Mukerjee R, Bagashev A, Del Valle L, Chabrashvili T, Hawkins BJ, He JJ and Sawaya BE: HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J Biol Chem 288: 8564, 2013.
60. Brew BJ, Crowe SM, Landay A, Cysique LA and Guillemin G: Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol 4: 163-174, 2009.
61. Noh H, Jeon J and Seo H: Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain. Neurochem Int 69: 35-40, 2014.
62. Zhou L, Miranda-Saksena M and Saksena NK: Viruses and neurodegeneration. Virol J 10: 172, 2013.
63. Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH and Grisham MB: T cell transfer model of chronic colitis: Concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 296: G135-G146, 2009.
64. Huber S, Schramm C, Lehr HA, Mann A, Schmitt S, Becker C, Protschka M, Galle PR, Neurath MF and Blessing M: Cutting edge: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173: 6526-6531, 2004.
65. Martinez FO and Gordon S: The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6: 13, 2014.
66. Crutcher KA, Gendelman HE, Kipnis J, Perez-Polo JR, Perry VH, Popovich PG and Weaver LC: Debate: 'is increasing neuroinflammation beneficial for neural repair?'. J Neuroimmune Pharmacol 1: 195-211, 2006.
67. Popovich PG and Longbrake EE: Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci 9: 481-493, 2008.
68. Tansey MG, McCoy MK and Frank-Cannon TC: Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 208: 1-25, 2007.
69. Schmid CD, Melchior B, Masek K, Puntambekar SS, Danielson PE, Lo DD, Sutcliffe JG and Carson MJ: Differential gene expression in LPS/IFNgamma activated microglia and macrophages: In vitro versus in vivo. J Neurochem 109 (Suppl 1): 117-125, 2009.
70. Block ML and Hong JS: Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog Neurobiol 76: 77-98, 2005.
71. González H, Elgueta D, Montoya A and Pacheco R: Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases. J Neuroimmunol 274: 1-13, 2014.
72. Henkel JS, Engelhardt JI, Siklós L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR and Appel SH: Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55: 221-235, 2004.
73. Mrak RE and Griffin WST: Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26: 349-354, 2005.
74. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR and Peterson PK: Role of microglia in central nervous system infections. Clin Microbiol Rev 17: 942-964, 2004.
75. Qian L, Tan KS, Wei SJ, Wu HM, Xu Z, Wilson B, Lu RB, Hong JS and Flood PM: Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. J Immunol 179: 1198-1209, 2007.
76. Gordon R, Anantharam V, Kanthasamy AG and Kanthasamy A: Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation. J Neuroinflammation 9: 82, 2012.
77. Magro F, Fraga S, Ribeiro T and Soares-da-Silva P: Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-γ upon L-DOPA uptake. Acta Physiol Scand 180: 379-386, 2004.
78. Panaro MA, Lofrumento DD, Saponaro C, De Nuccio F, Cianciulli A, Mitolo V and Nicolardi G: Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson's-like disease. Immunopharmacol Immunotoxicol 30: 729-740, 2008.
79. Querfurth HW and LaFerla FM: Alzheimer's disease. N Engl J Med 362: 329-344, 2010.
80. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN and Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211, 2003.
81. Saccon RA, Bunton-Stasyshyn RK, Fisher EM and Fratta P: Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain 136: 2342-2358, 2013.
82. Lu L, Lan Q, Li Z, Zhou X, Gu J, Li Q, Wang J, Chen M, Liu Y, Shen Y, et al: Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA 111: E3432-E3440, 2014.
83. Appel SH: CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. J Clin Invest 119: 13-15, 2009.
84. Reynolds AD, Stone DK, Mosley RL and Gendelman HE: Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells. J Proteome Res 8: 3497-3511, 2009.